Osteoporosis /
Saved in:
| Edition: | Fourth edition. |
|---|---|
| Imprint: | Amsterdam : Elsevier/Academic Press, 2013. |
| Description: | 1 online resource (2 volumes (xxv, 1995 pages, 18 unnumbered pages of plates)) : illustrations (chiefly color) |
| Language: | English |
| Series: | ClinicalKey ClinicalKey. |
| Subject: | |
| Format: | E-Resource Book |
| URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/11192443 |
Table of Contents:
- V: 1
- The bone organ system: form and function
- The nature of osteoporosis
- Reflections on osteoporosis
- Reflections on development of concepts of intercellular communication in bone
- Osteo-odyssey: a memoir
- Development of the skeleton
- The skeletal stem cell
- Osteoclast biology
- Osteoblast biology
- Osteocyte biology
- The regulatory role of matrix protein in mineralization of bone
- Parathyroid hormone and parathyroid hormone-related protein
- Vitamin D: biology, actions, and clinical implications
- Regulation of bone cell function by estrogens
- Androgens and skeletal biology: basic mechanisms
- Phosphatonins
- Skeletal growth factors
- Wnt signaling in skeletal homeostasis and diseases
- The mechanical behavior of bone
- Cellular and molecular mechanotransduction in bone
- Adaptation of skeletal structure to mechanical loading
- Biomechanics of hip and vertebral fractures
- Prevention of osteoporosis by physical signals: defining a potential role for nondrug strategies in the treatment of musculoskeletal injury and disease
- Epidemiologic methods in studies of osteoporosis
- Genetic determinants of osteoporosis
- Race, ethnicity, and osteoporosis
- Geographic variability in hip and vertebral fractures
- Nutrition and risk for osteoporosis
- Physical activity and exercise in the maintenance of the adult skeleton and the prevention of osteoporotic fractures
- Premenopausal reproductive and hormonal characteristics and the risk for osteoporosis
- Clinical and epidemiological studies: skeletal changes across menopause
- Osteoporosis in men: epidemiology, pathophysiology, and clinical characterization
- Falls as risk factors for fracture
- Nonskeletal risk factors for osteoporosis and fractures
- Outcomes following osteoporotic fractures
- Skeletal heterogeneity and the purposes of bone remodeling: implications for the understanding of osteoporosis
- On the evolution and contemporary roles of bone remodeling
- Cytokines and the pathogenesis of osteoporosis
- Animal models for osteoporosis
- Bone and fat
- Bone mineral acquisition in utero and during infancy and childhood
- Bone acquisition in adolescence.
- V: 2
- Osteoporosis in childhood and adolescence
- Osteoporosis associated with pregnancy
- Osteoporosis in premenopausal women
- Estrogen deficiency, postmenopausal osteoporosis, and age-related bone loss
- Immobilization osteoporosis
- Osteoporosis associated with illnesses and medications
- Glucocorticoid-induced osteoporosis
- Anticonvulsant-related bone disease
- Thyroid hormone and the skeleton
- The skeletal actions of parathyroid hormone in primary hyperparathyroidism and in osteoporosis
- Osteogenesis imperfecta and other defects of bone development as occasional causes of adult osteoporosis
- HIV and osteoporosis
- Obesity, diabetes, and fractures
- Osteoporosis in organ transplant patients
- Osteoporosis associated with rheumatologic disorders
- Osteoporosis associated with chronic kidney disease
- Oral bone loss and systemic osteoporosis: weighing the risk benefit ratio of treatment
- Cancer treatment-induced bone loss in patients with breast cancer: pathophysiology and clinical perspectives
- Pathophysiology-prostate cancer
- Mechanisms of bone destruction in myeloma
- Evaluation of the patient at risk for osteoporosis
- Imaging of osteoporosis
- Osteoporosis: who should be treated? Who should be screened?
- Clinical use of bone densitometry
- Biochemical markers of bone turnover in osteoporosis
- Fracture risk assessment: the development and application of FRAX®
- Orthopedic aspects of osteoporosis
- Falls prevention interventions
- Physical therapy, physical modalities, and exercise regimens in the management of osteoporosis
- Calcium in the treatment of osteoporosis
- Vitamin D and its metabolities and analogs in the management of osteoporosis
- Alternative therapy through nutrients and nutraceuticals
- Design considerations for clinical investigations of osteoporosis
- Lessons from bone histomorphometry on the mechanisms of action of osteoporosis drugs
- Estrogen and estrogen analogs for prevention and treatment of osteoporosis
- Androgens
- Calcitonin in osteoporosis
- Bisphosphonates: pharmacology and use in the treatment of osteoporosis
- Osteonecrosis of the jaw and atypical femoral fractures
- Condition critical: compliance and persistence with osteoporosis medications
- Denosumab for the treatment of osteoporosis
- Strontium ranelate in the prevention of osteoporotic fractures
- Parathyroid hormone treatment for osteoporosis
- New approaches to osteoporosis therapeutics
- The past, present, and uncertain future of therapeutic innovation in osteoporosis.